Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126188092 | 12618809 | 2 | F | 2016 | 20160801 | 20160803 | 20160809 | EXP | US-PFIZER INC-2016369703 | PFIZER | 59.00 | YR | F | Y | 69.00000 | KG | 20160809 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126188092 | 12618809 | 1 | PS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 80 MG, 1X/DAY | N | 20702 | 80 | MG | FILM-COATED TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126188092 | 12618809 | 1 | Blood cholesterol increased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126188092 | 12618809 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126188092 | 12618809 | Abdominal pain upper | |
| 126188092 | 12618809 | Diarrhoea | |
| 126188092 | 12618809 | Haematochezia | |
| 126188092 | 12618809 | Haemorrhage | |
| 126188092 | 12618809 | Pain in extremity | |
| 126188092 | 12618809 | Sleep disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126188092 | 12618809 | 1 | 20160729 | 2016 | 0 |